Guest writer Shayna Goerdt shares the ups and downs of her journey with MS. Among the highs is advocating for the community, ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability ...

Many MS genetic risk factors are shared across ancestral backgrounds, but European-focused studies may miss others, per a study.

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

Guest writer Caitlin Epstein was in the middle of world travels when her MS symptoms worsened, leading to a diagnosis.

For Izzy Abbass, who grew up around mountains, climbing them, and overcoming hurdles with MS, is easier with good support.

When guest writer Antonio Perez turned to social media to learn about MS, he saw a need to help other young people navigate ...

MS is causing fewer deaths and less disability now than in years past, and the trend will likely continue in the coming years, a study found.

Guest writer Reché Jones says it took her years to be diagnosed with relapsing-remitting MS. Now she plans to "keep moving." ...

Columnist Desiree Lama finds herself having to argue that a medicine that she has been taking for migraines for years is still needed.

MS patients are about twice as likely to develop restless legs syndrome than those without the disease, according to a study in Spain.